APOA1 and type 2 diabetes mellitus: However, the anti-inflammatory properties of HDL and ApoA1 are lost in patients with T2D, which is attributed to the non-enzymatic glycosylation of ApoA1 by reactive α-oxoaldehydes [55, 56].